Collaborate With MaxCyte®


The development of increasingly advanced biotherapies is generating substantial academic and industrial interest. With more diversity of choice, implementation of sophisticated cell manufacturing platforms and technologies can be time consuming, expensive and demanding of resources. To accelerate our partners’ therapeutic discoveries from concept to clinic, we take a collaborative approach at MaxCyte.

Discover more than just technology

We have spent over 20 years refining the art and science of electroporation and building our global team of cell engineering experts creating a best-in-class platform to support our collaborators. Technology alone won't get you where you want to go. And that's why we offer much more than just technology.


MaxCyte Electroporation Enables Faster Keratinocyte Engineering
This content was reproduced with the kind permission of Aaron Tward.

Shorten Development Timelines by Partnering with the ExPERTs

Our collaboration with the University of California, San Francisco enabled multiple process improvements:

  • Superior transfection efficiency while maintaining cell health
  • Highly efficient genome editing to eliminate cell enrichment and recovery steps
  • Flexible delivery of RNA and RNPs for multiplexed genome editing in multiple keratinocyte types​

Chart your best course forward with MaxCyte

Optimized technology supported by scientific experts can deliver transformative results. We partner with cutting-edge academic institutions, translational centers and biopharmaceutical companies across the world to enable better treatments and cures to transform human health.

Featured Collaboration Resources

Electroporation of a Non-Integrative DNA Nanovector for Efficient, Semi-Automated, GMP Manufacturing of CAR T Cell Therapies-min
Flow Electroporation® Technology: A Safe, Reliable and Effective Method for Engineering CAR T Cells
Scientific Brief
Generation of Heterozygous HLA-C iPSCs by ssODN Electroporation for Allogeneic Transplantation
Scientific Brief
Multiplex CRISPR-mediated Gene Editing Towards the Creation of a Universal CAR T Cell
View All Resources

Start collaborating with MaxCyte today!

Click below to learn how.

MaxCyte_Icons_Partnership 1